Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine A2A receptor

Details for Australian Patent Application No. 2004241720 (hide)

International Classifications

Event Publications

17 November 2005 PCT application entered the National Phase

PCT publication WO2004/103367 Priority application(s): WO2004/103367

1 December 2005 Amendment Made

The nature of the amendment is: Amend the invention title to read Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine A2A receptor

6 November 2008 Application Accepted

Published as AU-B-2004241720

5 March 2009 Standard Patent Sealed

8 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.